Sector Update: Healthcare Shares Higher Pre-Market: Intercept Pharma Up 30%, Adding to Thursday's Big Gains

By
A A A

Healthcare stocks:

JNJ: -0.57%

PFE: -0.65%

ABT: flat

MRK: flat

AMGN: flat

Healthcare shares are flat to higher in pre-market trade.

Shares of Intercept Pharma ( ICPT ) are back in the green this morning, rising nearly 30% pre-market after posting a whopping 280% rise in Thursday's regular session on the back of positive news on the company's liver drug.

ICPT hit a record high of $305 yesterday after the company said that its trial to study obeticholic acid (OCA) for the treatment of nonalcoholic steatohepatitis ( NASH ) has been stopped earlier than planned after already meeting the primary endpoint.

And, Immunomedics ( IMMU ) is 16% higher after it reported the first patient dosing in the company's Phase III registration study of its pancreatic cancer drug, yttrium-90 (90Y)-clivatuzumab tetraxetan.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: ICPT , IMMU , NASH

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

Stocks

Referenced

Most Active by Volume

64,789,752
  • $117.60 ▼ 0.86%
53,107,118
  • $10.39 ▼ 1.05%
42,600,857
  • $17.10 ▼ 0.47%
36,917,582
  • $11.02 ▼ 0.36%
34,902,121
  • $40.75 ▼ 0.10%
31,489,742
  • $15.68 ▲ 0.06%
31,037,743
  • $75.63 ▲ 2.19%
29,605,187
  • $10.11 ▼ 0.69%
As of 11/25/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com